The Group of Treatment Resistant Schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS)

por Kinon, Bruce J.
Publicado 2019

Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs

por Liu-Seifert, Hong, Adams, David H, Kinon, Bruce J
Publicado 2005

Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia

por Ascher-Svanum, Haya, Stensland, Michael, Zhao, Zhongyun, Kinon, Bruce J
Publicado 2005

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia

por Faries, Douglas E, Ascher-Svanum, Haya, Nyhuis, Allen W, Kinon, Bruce J
Publicado 2009

Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone

por Liu-Seifert, Hong, Kinon, Bruce J, Tennant, Christopher J, Sniadecki, Jennifer, Volavka, Jan
Publicado 2009

A Short-Term, Multicenter, Placebo-Controlled, Randomized Withdrawal Study of a Metabotropic Glutamate 2/3 Receptor Agonist Using an Electronic Patient-Reported Outcome Device in P...

por Stauffer, Virginia L., Baygani, Simin K., Kinon, Bruce J., Krikke-Workel, Judith O.
Publicado 2014

Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind Comparison

por Adams, David H., Zhang, Lu, Millen, Brian A., Kinon, Bruce J., Gomez, Juan-Carlos
Publicado 2014

Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia

por Liu-Seifert, Hong, Adams, David H, Ascher-Svanum, Haya, Faries, Douglas E, Kinon, Bruce J
Publicado 2007

Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia

por Ascher-Svanum, Haya, Nyhuis, Allen W, Faries, Douglas E, Ball, Daniel E, Kinon, Bruce J
Publicado 2010

Predictors of switching antipsychotic medications in the treatment of schizophrenia

por Nyhuis, Allen W, Faries, Douglas E, Ascher-Svanum, Haya, Stauffer, Virginia L, Kinon, Bruce J
Publicado 2010

Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of Schizophrenia

por Ascher-Svanum, Haya, Nyhuis, Allen W., Faries, Douglas E., Kinon, Bruce J., Baker, Robert W., Shekhar, Anantha
Publicado 2008

Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients’ and clinicians’ perspectives in a clinical trial

por Faries, Douglas, Ascher-Svanum, Haya, Phillips, Glenn, Nyhuis, Allen W, Sugihara, Tomoko, Stauffer, Virginia, Kinon, Bruce J
Publicado 2012

Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis

por Stauffer, Virginia L, Lipkovich, Ilya, Hoffmann, Vicki Poole, Heinloth, Alexandra N, McGregor, H Scott, Kinon, Bruce J
Publicado 2009

Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study

por Haynes, Virginia S, Zhu, Baojin, Stauffer, Virginia L, Kinon, Bruce J, Stensland, Michael D, Xu, Lei, Ascher-Svanum, Haya
Publicado 2012

The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragm...

por Chen, Lei, Johnston, Joseph A, Kinon, Bruce J, Stauffer, Virginia, Succop, Paul, Marques, Tiago R, Ascher-Svanum, Haya
Publicado 2013

The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial

por Chen, Lei, Phillips, Glenn, Johnston, Joseph, Kinon, Bruce J, Ascher-Svanum, Haya, Kollack-Walker, Sara, Succop, Paul, Naber, Dieter
Publicado 2011

A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care...

por Adams, David H, Kinon, Bruce J, Baygani, Simin, Millen, Brian A, Velona, Isabella, Kollack-Walker, Sara, Walling, David P
Publicado 2013

Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia

por Chen, Lei, Ascher-Svanum, Haya, Lawson, Anthony, Stauffer, Virginia L, Nyhuis, Allen, Haynes, Virginia, Schuh, Kory, Kinon, Bruce J
Publicado 2013

Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy

por Peng, Xiaomei, Ascher-Svanum, Haya, Faries, Douglas E, Stauffer, Virginia L, Kollack-Walker, Sara, Kinon, Bruce J, Kane, John M
Publicado 2011

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia

por Ascher-Svanum, Haya, Brnabic, Alan JM, Lawson, Anthony H, Kinon, Bruce J, Stauffer, Virginia L, Feldman, Peter D, Kelin, Katarina
Publicado 2012